Bodybuilders who compete at high levels die considerably younger than the general population, and the data paints a grim picture. A 2025 study in the European Heart Journal tracked deaths among male bodybuilding athletes and found a mean age at death of just 45.3 years, with sudden cardiac death accounting for a large share of those losses. That number comes with caveats worth unpacking, and the story changes depending on the era of bodybuilding, the level of drug use, and whether a competitor is male or female.
What the Mortality Data Actually Shows
The European Heart Journal study is one of the most rigorous attempts to quantify bodybuilding mortality. Researchers identified 121 deaths among male bodybuilders over the study period, with a mean age at death of 45.3 years and a range stretching from 22 to 77. The overall death rate was about 64 per 100,000 athlete-years, and sudden cardiac death alone occurred at a rate of roughly 24 per 100,000 athlete-years.1European Heart Journal. Mortality in male bodybuilding athletes To put that in perspective, sudden cardiac death rates in the general young adult population are far lower, typically estimated in the range of 1 to 3 per 100,000 per year.
It is worth understanding what that 45.3-year figure means and what it does not mean. It is the average age at death among bodybuilders who died during the observation window, not a life expectancy figure for all bodybuilders. Many competitors who are still alive were not captured. Still, even with that caveat, the number is striking, especially when a broad body of research shows that elite athletes in most other sports tend to live longer than the general public. A 2023 review in Sports Medicine noted this contrast directly: while a wealth of evidence shows elite athletes generally enjoy lower mortality rates, research specifically on bodybuilder lifespans remains surprisingly thin, and what does exist points in a troubling direction.2Europe PMC. Premature Death in Bodybuilders: What Do We Know?
How Bodybuilding Eras Changed the Longevity Picture
Not all bodybuilders through history have faced the same risks. A preprint analyzing mortality trends across three eras of bodybuilding, from 1900 to 1990, found dramatic differences depending on when competitors were active. Early practitioners in what researchers call the Bronze era lived to an average of about 75 years, and Silver era athletes (roughly the mid-20th century physique competitors) averaged around 80 years, actually outliving their contemporaries in the general population. The sharp decline came with the Golden era, when competitors averaged just 68.6 years and the difference from the Silver era was statistically significant.3SportRxiv. The Golden Paradox: Mortality Trends Across Three Eras of Bodybuilding (1900-1990)
The timing of that decline aligns with a clear historical shift: the emergence of widespread performance-enhancing drug protocols and the push toward increasingly extreme physiques. Bronze and Silver era bodybuilders built impressive physiques by the standards of their day, but the pharmacological arms race that began in the 1960s and accelerated through the 1970s introduced compounds and dosing patterns that appear to have fundamentally changed the risk calculus. The preprint’s authors argued that the high mortality rates seen in modern bodybuilding reflect specific contemporary practices rather than something inherently dangerous about resistance training itself.
The Heart Takes the Biggest Hit
Cardiovascular disease is the leading cause of death in bodybuilders who die prematurely, and the mechanisms are well documented even if large-scale epidemiological data remains limited. Anabolic-androgenic steroids damage the heart in multiple overlapping ways.
The most direct effect is on the heart muscle itself. A study of elite bodybuilders found that those using anabolic steroids developed thicker heart walls, specifically in the left ventricle’s posterior wall and the ventricular septum, without a corresponding increase in the heart’s internal chamber size. This pattern, known as concentric hypertrophy, makes the heart stiffer and less efficient at filling with blood between beats.4PubMed. Left ventricular size and function in elite bodybuilders using anabolic steroids A separate study comparing steroid-using weightlifters to non-users found even more alarming results: 10 of 12 steroid users had ejection fractions below the accepted lower limit of normal, meaning their hearts were pumping less blood per beat than a healthy heart should.5PubMed Central. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction
An analysis of autopsy reports from bodybuilders who died prematurely confirmed that these structural changes translate to real-world causes of death. Coroners listed heart disease, steroid-induced cardiomyopathy, sudden cardiac rhythm disturbances, and left ventricular hypertrophy among the causes. Among the subset where atherosclerosis was assessed and toxicology was performed, 80% showed atherosclerotic plaque and 60% tested positive for illicit drugs.6PubMed Central. Dead Bodybuilders Speaking from the Heart: An Analysis of Autopsy Reports of Bodybuilders That Died Prematurely One case report of a young bodybuilder who died suddenly showed coronary arteries narrowed by 75 to 80%, along with scarring and tissue death in the heart muscle.7Egyptian Journal of Forensic Sciences. Sudden cardiac testosterone-related death involving a young bodybuilder: autopsy, histopathological and toxicological findings
The vascular damage extends beyond the heart itself. Steroid users show higher blood pressure and stiffer arteries. One study found that current steroid abusers had average 24-hour systolic blood pressure readings of 132 mmHg compared to 124 in controls, and about half of the steroid users met criteria for systolic hypertension, roughly three times the rate in non-users. Both current and former users showed about 21% greater aortic stiffness than controls, suggesting that vascular damage persists even after stopping.8PubMed. Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids
Cholesterol changes compound the problem. An early study found that androgen use among bodybuilders and powerlifters lowered HDL cholesterol (the protective kind) by about 55% while raising LDL cholesterol by roughly 61%, resulting in a nearly three-fold increase in the LDL-to-HDL ratio, a strong predictor of coronary heart disease.9PubMed. High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use A separate case study documented a bodybuilder whose LDL doubled and whose HDL dropped by 90% during steroid use.10International Journal of Sports and Exercise Medicine. Extremely Low HDL Cholesterol and Increased LDL Cholesterol Induced by the use of Anabolic Steroids in a Body Builder: A Case Study
These lipid shifts accelerate plaque buildup in the coronary arteries. A pilot study of 14 professional bodybuilders with long histories of steroid use found that half had coronary artery calcium deposits, with six of the seven positive scores landing above the 90th percentile for their age, meaning their arteries resembled those of much older men.11PubMed. Coronary calcification in body builders using anabolic steroids A larger preprint from the Danish Fitness Doping study further found that cumulative lifetime duration of steroid use predicted coronary artery calcium scores and the presence of non-calcified plaque in both men and women, suggesting a dose-response relationship between years of use and atherosclerotic damage.12medRxiv. Impact of Androgenic Anabolic Steroids on Cardiovascular Health in Men and Women – PART OF THE FITNESS DOPING IN DENMARK (FIDO-DK) STUDY
Kidney and Liver Damage
The cardiovascular toll gets the most attention, but kidneys and liver also take serious damage in bodybuilders, particularly those combining high-dose steroids with extreme protein intakes and other supplements.
A study in the Journal of the American Society of Nephrology identified a cluster of 10 bodybuilders who developed focal segmental glomerulosclerosis, a form of kidney scarring, after long-term steroid abuse. Biopsies showed structural damage consistent with the kidneys being overwhelmed by the combined effects of increased lean body mass and the direct toxic effects of steroids.13PubMed Central. Development of focal segmental glomerulosclerosis after anabolic steroid abuse Individual case reports have documented the same pattern, with one bodybuilder developing this kidney disease after a decade of combined steroid use, extreme protein intake, and high-intensity training.14Polish Annals of Medicine. Focal segmental glomerulosclerosis as a rare side effect of combined anabolic-androgenic steroid use, high-protein diet and high-intensity anaerobic training A population-based study from the Middle East, however, found that the incidence of this type of kidney damage among bodybuilding supplement users was not statistically different from the general population, suggesting it may require the combination of steroids and other stressors rather than supplements alone.15PubMed Central. Effects of bodybuilding supplements on the kidney: A population-based incidence study of biopsy pathology and clinical characteristics among middle eastern men
The dietary component deserves its own mention. Very high protein intakes can increase pressure inside the kidney’s filtering units, leading to structural damage over time. Epidemiological studies link higher protein consumption to a more rapid decline in kidney function, and bodybuilders routinely consume protein at levels well above what has been studied for long-term safety.16PubMed Central. Nutritional and Non-Nutritional Strategies in Bodybuilding: Impact on Kidney Function
The liver faces its own risks. Oral anabolic steroids are processed through the liver and can trigger the growth of abnormal tissue. One documented case involved a 27-year-old bodybuilder who developed multiple hepatic adenomas, benign liver tumors that carry a risk of rupture and hemorrhage, directly linked to his steroid use.17PubMed Central. Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage Autopsy findings in other cases have revealed peliosis hepatis, a condition where blood-filled cavities form inside the liver, alongside the cardiac damage.7Egyptian Journal of Forensic Sciences. Sudden cardiac testosterone-related death involving a young bodybuilder: autopsy, histopathological and toxicological findings
Dangerous Substances Beyond Steroids
Steroids are the most discussed risk factor, but competitive bodybuilders commonly use a broader cocktail of substances that carry their own acute dangers. Contest preparation in particular introduces hazards that can kill quickly rather than slowly.
Diuretics are widely used before competitions to shed water weight and enhance muscle definition. A study of competitive Brazilian bodybuilders in a non-drug-tested federation documented the widespread use of diuretic drugs during peak week, noting these practices carry life-threatening risks including dangerous swings in potassium and sodium levels.18PubMed Central. Training, Pharmacological Ergogenic Aids, Dehydration, and Nutrition Strategies during a Peak Week in Competitive Brazilian Bodybuilders Severe dehydration combined with electrolyte imbalances has been implicated in several high-profile bodybuilder deaths, though these cases are difficult to study systematically because they happen sporadically.
Fat-burning compounds represent an even more acute danger. 2,4-dinitrophenol, or DNP, is an industrial chemical repurposed by bodybuilders for extreme fat loss. It works by disrupting the body’s energy production and converting it to heat, and even relatively small doses can cause fatal overheating. One case report described a 21-year-old bodybuilder who died after ingesting 2 grams of DNP following six months of regular use. Hair analysis confirmed chronic exposure alongside multiple anabolic steroids.19PubMed Central. Case report: Fatal long-term intoxication by 2,4-dinitrophenol and anabolic steroids in a young bodybuilder with muscle dysmorphia Another case documented the death of an apprentice bodybuilder from DNP-induced hyperthermia, with clenbuterol also found in his system, a beta-agonist that can cause dangerous electrolyte disturbances and coronary artery spasm.20PubMed. Death of an apprentice bodybuilder following 2,4-dinitrophenol and clenbuterol intake
Insulin is another underappreciated hazard. Bodybuilders use it for its effects on glycogen storage and perceived anabolic properties, but accidental overdose can cause fatal hypoglycemia. Growth hormone and IGF-1 are also commonly stacked alongside steroids, adding further metabolic stress.21ScienceDirect (Elsevier / Molecular and Cellular Endocrinology). Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects The polypharmacy aspect is critical: it is rarely one substance alone that kills. The typical competitive bodybuilder’s drug stack creates interactions that are almost impossible to study in controlled settings because no ethics board would approve the combinations and dosages involved.
Female Bodybuilders Face Lower but Real Risks
Most mortality research on bodybuilders has focused on men, but a 2025 study published in the European Heart Journal specifically examined female bodybuilding athletes. The overall death rate was about 34 per 100,000 athlete-years, roughly half the rate seen in males. Sudden cardiac death occurred at a rate of about 10 per 100,000 athlete-years, and among professional female competitors, the rate was substantially lower still compared to professional males.22PubMed Central. Mortality in female bodybuilding athletes
The gap likely reflects several factors. Women in bodybuilding generally use lower doses of performance-enhancing drugs, though use is far from absent. Female competitors also tend to carry less overall muscle mass, which means lower cardiac strain at baseline. That said, “lower than male bodybuilders” is not the same as “safe.” The female death rate still appears elevated compared to women in the general population and women in most other sports. The research on female bodybuilder mortality is even thinner than the male literature, so these numbers should be read cautiously.
Drug-Free Bodybuilders Are Not Off the Hook
A common assumption is that avoiding performance-enhancing drugs makes competitive bodybuilding a purely healthy pursuit. The reality is more complicated. A 2025 review noted that natural bodybuilders who avoid drug use still face significant health risks from extreme diets and training regimens. Achieving competition-level body fat, sometimes in the low single digits for men, requires prolonged caloric restriction that disrupts hormonal function, immune response, and bone metabolism. The repeated cycle of bulking and cutting that defines a competitive season subjects the body to metabolic stress that can contribute to cardiovascular problems and hormonal imbalances even without any drug involvement.23Korean J Sports Med. The Medical Challenges of Bodybuilding: Health Risks of Drugs, Extreme Training, and Dieting
Whether these risks translate to meaningfully shorter lifespans in drug-free competitors remains unknown. No study has tracked natural bodybuilders over decades to determine mortality rates. The health concerns are real, but they are likely on a different scale from those seen in drug-using competitors whose hearts are being remodeled by years of anabolic compounds.
The Psychological Dimension
Longevity in bodybuilding is not purely a pharmacological or physiological question. Psychological patterns common in the sport contribute to risk by driving the behaviors that cause physical harm. Muscle dysmorphia, a form of body image disturbance where a muscular person perceives themselves as small or insufficiently developed, is substantially more common among steroid users. A meta-analysis found that steroid-using populations had markedly higher odds of muscle dysmorphia symptoms compared to non-users, and the condition correlated with obsessive-compulsive traits.24PubMed Central. Muscle Dysmorphia, Obsessive-Compulsive Traits, and Anabolic Steroid Use: A Systematic Review and Meta-Analysis Network analysis among male weightlifters confirmed that steroid users showed elevated muscle dysmorphia symptoms compared to controls.25PubMed Central. Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters
This matters for longevity because muscle dysmorphia drives escalating drug use, resistance to medical advice, and continued training through injuries. A qualitative theme that repeatedly emerges in research on steroid-using bodybuilders is limited engagement with healthcare services. People who are psychologically compelled to pursue ever-larger physiques are unlikely to moderate their drug use in response to early warning signs like elevated blood pressure or abnormal blood work. The condition creates a feedback loop: the drugs facilitate the pursuit of an ideal physique, the pursuit intensifies the psychological disturbance, and the disturbance discourages the kind of medical monitoring that might catch problems early.
What Happens When Bodybuilders Stop
For competitors who survive their active years and discontinue steroid use, recovery is possible but uneven. A scoping review found that physical changes like testicular shrinkage tend to reverse over months to years, and testosterone production typically returns to near-normal levels. Sperm production also recovers, though the timeline varies. However, some effects are less reversible: gynecomastia (breast tissue growth) is unlikely to resolve without surgery, and the psychological adjustment can be rocky, with a transient withdrawal period that may be followed by lingering lower-level symptoms.26PubMed Central. Physical, psychological and biochemical recovery from anabolic steroid-induced hypogonadism: a scoping review
What remains less clear is whether the cardiovascular damage reverses. Arterial stiffness appears to persist in former users at levels similar to active users, and coronary artery plaque does not go away once formed. A bodybuilder who used heavily for a decade and then stopped might recover hormonal function but still carry a heart and vascular system that has aged far beyond their calendar years. The research simply has not followed enough former users for long enough to know whether stopping changes the survival curve in a meaningful way.